BVT Knock-Out IDXX/ DE000VD1Y629 /
14/06/2024 08:22:43 | Var.-0.020 | Denaro08:27:09 | Lettera08:27:09 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.560EUR | -3.45% | 0.570 Quantità in denaro: 5,200 |
0.610 Quantità in lettera: 5,200 |
IDEXX Laboratories I... | 566.32 USD | 31/12/2078 | Put |
GlobeNewswire
09:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
09:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
09:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
09:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
08:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
07:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...